Results 171 to 180 of about 28,587 (212)

Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States

open access: hybrid, 1995
Henry H. Bernstein   +14 more
openalex   +1 more source

Characterization of Bactericidal Immune Responses following Vaccination with Acellular Pertussis Vaccines in Adults

open access: green, 2000
Christine L. Weingart   +3 more
openalex   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Pertussis vaccines

Current Opinion in Pediatrics, 2022
Purpose of review Pertussis is a vaccine preventable cough illness. It can be controlled by universal pertussis vaccination. Recent findings Pertussis cases and deaths in children are at a record low number.
James D, Cherry, Saba, Doustmohammadi
openaire   +2 more sources

Pertussis vaccine controversies and acellular pertussis vaccine

The Indian Journal of Pediatrics, 2003
Pertussis still continues to cause significant morbidity and mortality worldwide. Because of the high reactogenicity of whole cell pertussis vaccine, it had evoked public controversy in several countries. In 1970 Japan abandoned use of whole cell pertussis vaccine and mounted efforts to develop better vaccine.
Raju C. Shah, Anuj R. Shah
openaire   +2 more sources

Pertussis Vaccines

Pediatric Clinics of North America, 1990
Concern over adverse reactions temporally associated with whole cell pertussis vaccine and advances in the understanding of the Bordetella pertussis organism have led to a new generation of more purified acellular vaccines. The biology of the pertussis organism, epidemiology of disease, vaccine development over the decades, and vaccine efficacy and ...
K M, Edwards, D T, Karzon
openaire   +2 more sources

Home - About - Disclaimer - Privacy